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Methicillin-resistant Staphylococcus aureus (MRSA) has captured 
national headlines. In the fall of 2007, the CDC (Center for Disease 
Control in Atlanta) reported that deaths due to MRSA were greater 
than those caused by AIDS. MRSA is rapidly becoming one of the 
most prevalent and menacing diseases of our time and increases the 
risk of time spent in a hospital.
MRSA are bacteria that represent “new” strains of antibiotic 
resistant Staphylococcus aureus (ﬁ g. 1). Although the media 
discusses MRSA as a single new strain, in reality MRSA represents 
more than 1100 distinct strains of S. aureus.1 S. aureus causes many 
diseases, including skin boils, infection of leg ulcers, and pressure 
sores. Occasionally, it can cause more serious disorders such as 
blood poisoning (septicemia), pneumonia, or bone, joint, or heart 
valve infection. What makes MRSA bacteria deadly is their resistance to penicillin and its derivatives.
Methicillin is a penicillin derivative that was issued in clinics in most countries in 1959–60, but its use was 
discontinued after 1961 due to resistant strains appearing. Unfortunately, resistance has increased dramatically 
since 2000. These bacteria are now categorized as Hospital-Associated MRSA (HA-MRSA) and Community-
Associated MRSA (CA-MRSA) depending upon the disease acquisition location.
Yet, we read in Genesis Chapter 1 that God made everything “very good.” If everything that God made 
was good, where did MRSA come from? What is the origin of this frightening germ? Where does MRSA or 
“Super Staph” ﬁ t in to the creation account? Were they created along with the rest of the life in the ﬁ rst week of 
Creation or were they created later—after the Fall? Is MRSA a result of the “Curse”? These and other questions 
have been asked by professional creation microbiologists.2–4 Their answers may surprise you.
The purpose of this article is to provide a reasonable explanation for the genesis of MRSA (“Super Staph”). 
Microbiology research based on the creation paradigm appears to provide some answers to these puzzling 
questions regarding the Staphylococcus “kind” (Family Micrococcidae). Although I cannot be dogmatic 
(beyond the biblical text) regarding details of microbe origin during Creation Week, I believe that a reasonable 
extrapolation from Scripture and biological data can be made about the nature of microbes in a fully mature 
creation. Diligent research by past creation biologists5 such as Leeuwenhoek, Pasteur, and Lister, were blessed 
by God as He revealed (Psalm 139:17a) to them critical insight into His creation.6
Pre-Fall World, Normal Flora, and Characteristics of Human Skin
Before answering these questions, some background is needed regarding the pre-Fall world, normal ﬂ ora 
(that is, fungi and bacteria), and skin characteristics in particular. Where do the MRSA microbes ﬁ t into God’s 
“very good” creation?
Most creation biologists believe that God created (Genesis 1) all bacteria as very good forms of life.7, 8 Even 
today, a vast majority of bacteria are beneﬁ cial to man and nature. Only about 5–10% of all bacteria are 
pathogenic. Many microbes live in a mutualistic relationship with other microbes, but they also reside with 
plants, animals, and humans. Mutualism is a type of symbiosis (Greek sym; together, bios, life). It is “normal” 
and critical for our body’s health to be symbiotically inhabited by microbes such as beneﬁ cial bacteria. God’s 
very good creation included design features involving important microbes. This external beneﬁ cial colonization 
of the body is termed our normal microbiota or ﬂ ora.
In some cases the symbiosis is beneﬁ cial to both the body and the microorganisms; this relationship is 
Fig. 1. MRSA photo showing the golden 
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called mutualism. Man is “covered” inside and outside his body with millions of microbiotic organisms (that is, 
normal ﬂora) to maintain normal bodily functions and sustain life in changing environments. The human skin 
contains about 3 million bacteria per cm3 (many more than the number of our own larger epidermal cells). Many 
Staphylococcus and Micrococcus species live on human skin and derive nutrients from the environment while 
producing acid to prevent the overgrowth of pathogenic organisms. S. epidermidis alone makes up 90% of the 
normal ﬂora on the skin.9, 10 The normal ﬂora provides clues to the pre-Fall function of bacteria.
The skin provides a microbiome for many bacteria. Dr. Joseph Francis11 suggests the microbes are a natural 
healthy extension of the body and the bacteria form a biomatrix (technically an organosubstrate) on the 
epidermis. In a brilliant stroke, the Creator most likely wove together man’s skin with a Staphylococcus kind.12 
Just like an embroidered quilt, He made humans with bacteria on their skin and in their intestines. When God 
created man, most likely He made the Staphylococcus kind to help maintain and protect the skin and other 
integumentary surfaces.
Over time, minor changes took place (that is, variation): some of 
the Staphylococcus kind became S. epidermidis to occupy most of 
the body’s surface. S. epidermidis seems quite adapted to living on 
the dry and salty skin. On the other hand, S. aureus tends to occupy 
moist places of the body like the nose, mucous membranes, and folds 
of the armpits and groin. Perhaps, the original Staphylococcus kind 
diversiﬁed into several varieties according to microhabitat: some to 
live on the dry skin and some to live on moist skin. (S. aureus and S. 
epidermidis are two of 31 identiﬁed Staphylococcus species, ﬁg. 2).
Staphylococcus aureus is a bacterium that can frequently live 
harmlessly in the nose and occasionally on the skin in a state known 
as colonization.13 Most likely, S. aureus was originally designed to 
live in harmony with man as a harmless normal ﬂora. Perhaps it 
played a positive role in the recycling of cell components in nose or 
skin as its “cousin” S. epidermidis did in its original good design. After the Fall, the Curse given by the Creator 
caused corruption and decay to the genetic code of bacteria. Today, the term germ speciﬁcally refers to disease-
causing microbes or pathogens.14 A pathogen is a microbe capable of causing host damage. All “germs” would 
have their origin after the Fall (Genesis 3). The Edenic Curse would have profoundly inﬂuenced all Creation, 
including viruses, bacteria, fungi, and protozoans that would later become pathogens or parasites.
Clearly, the origin of infectious disease is complex and multifaceted (ﬁg. 3). This topic is further explored in 
the book The Genesis of Germs.15 It provides some understanding into the origin of infectious diseases. From 
a biblical worldview, infectious diseases and pathogenesis became a secondary condition and not what the 
Creator intended. As research continues, the mutualistic relationship of prokaryotes and people is seen to be 
more intimate than ever. Many of the skin’s microbiota are now known to secrete chemicals that interfere with 
the growth of pathogens.16
Staphylococcus Kind Becomes Corrupt
The Staphylococcus “kind” is a rather hardy Gram-positive bacteria type and is especially resistant to drying. 
These bacteria usually occur in large grape-like clusters (32–64 cells), but can be observed individually or in two-
, four-, eight-, or 16-cell or larger chains at a time (ﬁg. 2). These tiny spheres measure about one µ in diameter. 
Staphylococci grow at a variety of temperatures and oxygen conditions but seem to do especially well at normal 
body temperature (37 °C) and on the surface of skin and mucous membranes.17 It seems conceivable that after 
the Fall, some of the Staphylococcus kind became corrupted by the addition of genetic material (pathogenicity 
islands and bacteriophages carrying foreign DNA segments), as well as by the loss of chromosomal DNA. 
Modiﬁcation and displacement of the Staphylococcus kind led to its pathogenicity. Today, S. epidermidis only 
shows a “trace” of modiﬁcation and remains a beneﬁcial microbe. Conversely, S. aureus shows large genetic 
components that seem to have been added and a few genes that have been lost. 
The pathway to pathogenicity for Staphylococcus appears to result from several major traits that have been 
added, including genes that code for a toxin, ﬂesh stripping (exfoliative) enzymes, and traits that help bacteria 
avoid phagocytosis by white blood cells (table 1). These traits may have come from displacement of genes from 
neighboring bacteria. One of the major enzymes is staphylococcal coagulase, a corrupting factor in plasma that 
initiates clot formation.18 In today’s post-Fall world, S. aureus is far more virulent than S. epidermidis. In fact, 
it is the most virulent of all the Staphylococci and Micrococci.19 It lives permanently in the nose for 20% of the 
human population. Up to 80% of the American population are carriers of S. aureus at some point in their lives. 
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This poses a danger to the public because these bacteria can survive for months on moist surfaces. S. aureus are 
typically yellow, golden, or orange tinted. In contrast, S. epidermidis are white or cream colored. The pigment 
in S. aureus provides it with protection against the sterilizing rays of UV light. S. aureus that are exposed to 
UV light lose their pigment and are more likely to be phagocytized by the body’s white blood cells and are less 
harmful than their pigmented cousins.
Pathway to Pathogenicity
S. aureus has a signiﬁcantly larger genome than S. epidermidis. Most strains of S. aureus have a genome 
size of 2.8+ Million Base Pairs (MBP) and most strains of S. epidermidis have a size of 2.5–2.6+ MBP. They 
share about 67% (2/3) of the same genes. It appears that S. aureus has gained about 300,000 DNA base pairs, 
many of which are factors that lead to its pathogenicity and ability to avoid the body’s defense system.21 As we 
examine many other important bacteria pathogens, it appears that a “recipe for corruption” is this: the addition 
of unnecessary DNA, the loss of purposeful information, and the mixing of “foreign seed” (DNA from other 
microbes) with original kind “seed” (DNA of original S. aureus).
Lateral transfer of DNA may be beneﬁcial to the bacteria for a season. Virulence seems to commonly arise via 
mechanisms of conjugation, pathogenicity island transfer, bacteriophage insertion, and loss of metabolic coding 
information (ﬁg. 3). For example, bacteriophages (viruses that infect S. aureus) are known to carry incomplete 
or corrupted genes that are then spliced into the genome of the host they infect. In addition, pathogenicity 
islands via conjugation have been transferred from other bacteria adding new virulence factors. The most 
signiﬁcant lateral transfer appears to be the addition of chromosomal DNA cassettes (pathogenicity islands) 
from neighboring bacteria.22 
Fig. 3. A multifaceted model for the genesis of germs.20
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The vast majority of S. aureus are positive for coagulase production. This means that bacteria can produce 
an enzyme that coagulates blood—turning ﬁbrin into insoluble ﬁbrinogen—the protein that makes a blood clot 
look a crusty-brown ﬁsherman’s net. It appears that coagulase causes ﬁbrin to be deposited around the cocci 
and prevents macrophages and neutrophils from engulﬁng (via phagocytosis) the Staph bacteria.
Virulence Factor S. epidermidis S. aureus
Toxins  
Cytolytic, a - Hemolysins - +
Leukocidin - +
Exfoliative - some strains
Enzymes
ß-Lactamase - 90% of strains
Coagulase - +
Hyaluronidase - +
Lipase + +
Staphylokinase - +
Phagocytic Inhibitors
Capsule - +
Protein A - +
Polysaccharide slime layer + +
Table 1. Comparison of the two major Staphylococcus types.23–25
■ 1872. Sir Joseph Lister, Christian and British physician, is inﬂuenced by Louis Pasteur’s work on infectious 
agents, uses phenol (carbolic acid) directly on wounds and surgical dressings, preventing most post-operative 
infections. He sees cocci in clusters (possibly Micrococcus) but does not make full connection of cause and 
effect with inﬂammation.
■ 1879. Louis Pasteur, creation microbiologist, discovers small, rounded bacteria in grape-like clusters. He 
ﬁnds the bacteria in the pus from the neck of his lab assistant, Emile Duclaux. He associates these bacteria 
with both furuncles (boils) and later osteomyelitis in the tibia.26
■ 1880. Staphylococcus pyogenes aureus is identiﬁed as the cause of wound infection by the Scottish surgeon 
Sir Alexander Ogston, who named it for the grape-like clusters (in Greek, staphyle) he observed under the 
microscope (the ﬁrst name given to S. aureus).
■ 1881. Robert Koch notices work of Alexander Ogston and expands study of S. aureus. He reports that it is the 
most common cause of wound infections in hospitals.
■ 1884. Staphylococcus pyogenes aureus is isolated and distinguished from S. epidermidis by German scientist 
Anton Rosenbach, who grows the two strains, S. aureus (“golden staph,” for the golden colonies it grows on 
bacterial media) and S. albus (white colonies, now called S. epidermidis) in pure culture.
■ 1891. Joseph Lister publishes a paper that carboxylic acid is needed to prevent S. aureus surgical infections. 
He applies it to patients during surgery.
■ 1928. Alexander Fleming discovers penicillin.
■ 1930s. The coagulase test is invented enabling bacteriologists to rapidly detect a coagulating enzyme secreted 
by S. aureus. Coagulase-positive S. aureus are among the most severe pathogenic strains.
■ 1941. S. aureus blood infections have a mortality rate of 81% in a Boston hospital. The same year, a British 
policeman seriously ill with S. aureus is cured by penicillin.
■ 1944. Widespread use of penicillin cures many staph infections after D-Day. The “miracle drug” mentality 
leads to lapses in aseptic protocols and “more is better.” By 1946, Alexander Fleming warns that penicillin-
resistant staph will increase.30
■ 1961. Methicillin-resistant S. aureus (MRSA) is ﬁrst detected in a British hospital; during the next 10 years, 
MRSA becomes widespread in Europe, the USA, and Australia.
■ 2007. CDC reports more U.S. deaths due to MRSA than AIDS in 2005.
■ 2008. MRSA reports skyrocket in public schools.
Table 2. The history of a hospital menace, Staphylococcus aureus.27–29
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As S. aureus evades the body defenses, they then begin to secrete various enzymes to gain further expansion 
into the human body. These enzymes include hemolysins and leukocidins. They are able to cause the hemolysis 
(splitting) of erythrocytes (red blood cells) and secrete a leukocidin that destroys leukocytes (white blood cells). 
In addition, the added DNA codes for toxins and injurious chemicals that facilitate its spread across the skin, 
mucous membranes, and other body surfaces. The consequences to the Staph invasion can lead to harmful 
impetigo, ﬂesh-eating effects, septicemia (blood poisoning), and, in the GI tract, food intoxication.31, 32
The Providential History of Staphylococcus Discovery
The history of Staphylococcus aureus is very interesting and involves a number of Protestant and Roman 
Catholic scientists. The earliest observers were “evangelical” Quakers: Joseph Lister and Alexander Ogston. 
Both are reported to have been humble Christians who wanted to heal patients of dreaded surgical and wound 
infections.
Creation microbiologist, Louis Pasteur was one of the ﬁrst to report the tiny grape-like cluster of bacteria in 
boils (later named Staphylococcus aureus). Due to other more pressing projects, such as anthrax and rabies, 
he did not further pursue the study of S. aureus. Instead the Scottish surgeon Alexander Ogston described the 
nature of Staphylococci. He worked with Joseph Lister to eliminate them in hospital operating rooms.
The German Anton Rosenbach built upon Ogston’s work and would be the ﬁrst to distinguish the 
Staphylococci “kind”—the golden ones as Staphylococcus pyogenes aureus (now called S. aureus) and the white 
ones as Staphylococcus albus (now called Staphylococcus epidermidis.) The next major breakthroughs came 
when Alexander Fleming was ﬁrst working with bacteria isolated from soldiers’ wounds in WWI. In 1921, 
he isolated lysosome from tears that was produced in response to the Staphylococcus “kind.” He became the 
leading expert on S. aureus. Then, in 1928, his most famous discovery, penicillin, was produced by a mold that 
inhibited the growth of S. aureus.
By the early 1940s, penicillin became the most common antibiotic for wound treatment in soldiers in WWII. 
Fleming predicted the indiscriminate use of the now “miracle” drug, would lead to resistance. Indeed, by 1946 
penicillin resistance in S. aureus was observed in many patients around the world. In 1945, during his Nobel 
Prize speech acceptance, he gave credit to the Creator and Providence for leading him in to this “serendipitous” 
discovery. Fleming was a Roman Catholic who saw Providence directing him through life and suggesting an 
“Angel” had “stirred up the waters” for the Penicillium mould to mix with S. aureus on the Petri plate that 
August (1928) day.33
The Pathway to Antibiotic and Multiple Drug Resistance
Staphylococcus aureus is a classic example of expanding during resistance. It quickly developed penicillin 
resistance soon after WWII. S. aureus later acquired resistance to methicillin, then to third-generation 
penicillins, and now to powerful drugs, including one of the last of the front-line antibiotics, vancomycin. Like 
many other hospital terrors, these bacteria, which were once considered to be relativity harmless microbiota of 
the skin, acquired multiple drug resistances and additional virulence traits from environmental commensals. 
One such virulence factor is the carotenoid pigment staphyloxanthin that gives S. aureus its golden color. 
Staphyloxanthin helps this pathogen evade host destruction by reactive oxygen (from hydrogen peroxide) 
sequestered within the host’s neutrophils.34
Methicillin was ﬁrst administered to hospital patients in the UK in 1959, and by 1961, resistance developed. 
Research has shown the MRSA strains have emerged more than one time since 1961. The mechanism for 
horizontal (or lateral) gene transfer varies widely by bacterial strains. In general, methicillin resistance arises 
by acquisition of a staphylococcal cassette chromosome SSCmec (a pathogenicity island or mobile gene complex) 
and is coded by the mecA gene.35 The protein expressed is PBP2, a penicillin-binding protein.36 (Penicillin-
binding proteins are enzymes that bind Staph’s cell wall.) This “new” penicillin binding protein has reduced 
attraction for the characteristic and critical ß-lactam ring, the major active-site of the ß-lactam antibiotics, such 
as penicillin and methicillin. MRSA with its new PBP2 disrupts the drug’s action and renders the antibiotic 
ineffective. Since the emergence of MRSA in the 1960s, more than two dozen strains resistant to methicillin 
have independently arisen, and many of these are also resistant to vancomycin and a dozen more antibiotics. 
MRSA and its “cousins” have become a hospital terror over the past decade.
Summary and Conclusions
MRSA could be modern-day type of “leprosy” (Hebrew tsara’ath), a contagious disease in the Bible. Leprosy 
is most described in Leviticus, where it primarily refers primarily to an infectious skin disease. A person with 
any scaly skin blemish was tsara’ath.37 There is no precise, written historical record of how, when, where, or 
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why infectious diseases like MRSA began. The Bible does not say exactly when contagious diseases caused by 
Staphylococcus ﬁrst arose; so, creationists and evolutionists have formulated their ideas regarding the origin of 
diseases based upon limited evidence.
In the beginning, God declared all that He had created to be very good (Genesis 1). Due to the Edenic 
Curse (Genesis 3) and subsequent decay and corruption, some bacteria became pathogenic. Most likely, the 
Staphylococcus kind was meant to inhabit the skin and body surfaces, mucous membranes, nose, etc. It appears 
that over a few thousand years, corrupted genes were added that coded for toxins, virulence enzymes, and a 
decreased body defense by the human host (phagocytosis inhibited.)
The skin and immune system seems to have declined over time, as evidenced by shorter human life spans 
than those of the early chapters of Genesis, as well as decreased phagocytic ability in handling Staph. The origin 
of Staph-virulence genes is both complex and multifaceted, but may be explained by a combination of genes 
being lost, added, or moved. S. aureus may have lost its ability to grow on very dry surfaces (microbiomes) of 
the skin; whereas, its ‘cousin’ S. epidermis can still survive there. One example of a “corruption” of mobile genes 
is the lateral transfer of pathogenicity islands that code for the enzymes coagulase and staphylokinase, as well 
as exfoliative, hemolysin, and leukocidin toxins. The story of S. aureus’ degeneration into the MRSA pathogen 
may serve as a model of “fast” genomic variation, decay and corruption—not upward, onward evolution. In fact, 
both the original and ﬁnal forms are still Staphylococcus bacteria.
The corruption and decay of the Staphylococcus kind is due a loss of DNA bases (deletion), as well as some 
DNA base insertions, resulting in damage to the original genetic information. For example, bacteriophages 
(viruses that infect S. aureus) are known to carry incomplete or corrupted genes that are then spliced into the 
genome of the host they infect. In addition, pathogenicity islands have been transferred from other bacteria to S. 
aureus via conjugation adding new virulence factors. Some of MRSA’s antibiotic genes appear to have been added 
to its existing plasmids; S. aureus has obtained both chromosomal, toxin genes from a pathogenicity islands in 
Enterococcus species. This new information is a corruption of Staphylococcus’ original chromosomal DNA.
Virulence factors (such as coagulase) play a small role in infections; however, none is considered a primary 
cause of the highly virulent disease. It is the sum of all the virulence factors that make S. aureus a particularly 
dangerous infection. The interaction and cumulative effects of the virulence factors and corruptions of the 
body’s immune system are important in whether they are fatal, or life threatening. Because some strains of 
S. aureus are able to evade and disable the immune system, they can cause signiﬁcant damage by entering
the bloodstream and heart, thus making them lethal. By contrast, a healthy person’s immune system can still
prevent progress of many virulent MRSA infections, even with many virulent factors.
Staphylococcus aureus has likely been a pathogen for a long time: boils have been known since the time 
of Job! However, in the 1940s, penicillin provided a temporary cure for everyone. But by the late 1940s, the 
miracle was eroding. As more antibiotics were manufactured, the bacteria developed resistance, and by 1960s, 
MRSA emerged. Today, it is estimated that more than 95% of hospital patients with S. aureus are resistant to 
ﬁrst and second generation antibiotics like penicillin, ampicillin, and methicillin.
MRSA is sometimes called “Super Staph” or the “Superbug” in the press because of its resistance, its ability 
to cause infections in hospitalized patients, and its capacity to cause outbreaks on wards. The reason that 
hospitals seem to be hotbeds for resistant MRSA is because many different strains of it are being thrown 
together with many doses of antibiotics, vastly accelerating a natural selection for resistance.
The key to MRSA control is the prompt treatment with effective antibacterial drugs. But a Christian, the 
seeking of Jehovah Rapha, The Great Physician, is important: God has revealed Himself as Jehovah Rapha 
in the context of great sickness occurring all around His people. Rapha means “to cure, to repair, to heal, to 
mend back together” or “to restore one to health or usefulness”.38 Usually the word, heal, or healing is used in 
conjunction with Jehovah Rapha. “Healing” implies: sewn together, or stitched. God is involved in the restoration 
by sewing things together that are torn apart. This is the nature of Jehovah Rapha. MRSA infections tear the 
skin and have the capacity to destroy a life. God is the Creator of the human body and the Staphylococcus kind 
and what He has made He can restore. After all, what He has made, He can heal.
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